The stock of Mynd.ai Inc ADR (MYND) has seen a 16.50% increase in the past week, with a 48.41% gain in the past month, and a 167.79% flourish in the past quarter. The volatility ratio for the week is 14.13%, and the volatility levels for the past 30 days are at 19.70% for MYND. The simple moving average for the past 20 days is 3.68% for MYND’s stock, with a -1.92% simple moving average for the past 200 days.
Is It Worth Investing in Mynd.ai Inc ADR (NYSE: MYND) Right Now?
Moreover, the 36-month beta value for MYND is 1.28. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MYND is 45.41M and currently, short sellers hold a 0.04% of that float. On December 27, 2024, MYND’s average trading volume was 145.36K shares.
MYND) stock’s latest price update
Mynd.ai Inc ADR (NYSE: MYND)’s stock price has soared by 15.92 in relation to previous closing price of 2.01. Nevertheless, the company has seen a gain of 16.50% in its stock price over the last five trading days. newsfilecorp.com reported 2024-11-22 that Vancouver, British Columbia–(Newsfile Corp. – November 22, 2024) – MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (“MYND” or the “Company”), a leader in mental health diagnostics and treatments, today announced two significant strategic decisions aimed at strengthening the company’s financial position and governance. These moves demonstrate a strong commitment to the company’s vision and strategic plan to commercialize a diagnostic biomarker test for depression which is being initially developed for the purpose of diagnosing and monitoring those with major depressive disorder (MDD).
MYND Trading at 29.64% from the 50-Day Moving Average
After a stumble in the market that brought MYND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.45% of loss for the given period.
Volatility was left at 19.70%, however, over the last 30 days, the volatility rate increased by 14.13%, as shares surge +30.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +75.19% upper at present.
During the last 5 trading sessions, MYND rose by +16.50%, which changed the moving average for the period of 200-days by -49.91% in comparison to the 20-day moving average, which settled at $2.25. In addition, Mynd.ai Inc ADR saw -57.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MYND
Current profitability levels for the company are sitting at:
- -0.11 for the present operating margin
- 0.25 for the gross margin
The net margin for Mynd.ai Inc ADR stands at -0.09. The total capital return value is set at -0.19. Equity return is now at value -170.20, with -42.26 for asset returns.
Based on Mynd.ai Inc ADR (MYND), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at -0.02. The debt to equity ratio resting at 0.82. The interest coverage ratio of the stock is -9.39.
Currently, EBITDA for the company is -36.38 million with net debt to EBITDA at -0.48. When we switch over and look at the enterprise to sales, we see a ratio of 0.3. The receivables turnover for the company is 6.48for trailing twelve months and the total asset turnover is 1.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.
Conclusion
To wrap up, the performance of Mynd.ai Inc ADR (MYND) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.